Recent Quarter Total Invested
$1.61 B
Recent Quarter Institutional Ownership Percentage
94.66%
Total Invested of Last Quarter
$1.66 B
Ownership Percentage of Last Quarter
95.88%
Kura Oncology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 7.65 M | $149.54 M | 8.25% | 8.80% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.16 M | $139.82 M | 100.00% | 8.23% |
ECOR1 CAPITAL, LLC | 11/14/2024 | 5.81 M | $113.47 M | 0.00% | 6.68% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 5.41 M | $105.74 M | 0.00% | 6.22% |
PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 4.33 M | $84.63 M | -4.58% | 4.98% |
AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 3.54 M | $69.20 M | 0.00% | 4.07% |
BVF INC/IL | 11/14/2024 | 3.37 M | $65.88 M | -17.40% | 3.88% |
HOLOCENE ADVISORS, LP | 11/14/2024 | 2.69 M | $52.55 M | 0.00% | 3.09% |
STATE STREET CORP | 11/14/2024 | 2.67 M | $52.15 M | -7.48% | 3.07% |
ARMISTICE CAPITAL, LLC | 11/14/2024 | 2.66 M | $51.94 M | 13.11% | 3.06% |
DEEP TRACK CAPITAL, LP | 11/14/2024 | 1.96 M | $38.37 M | 410.32% | 2.26% |
FORESITE CAPITAL MANAGEMENT IV, LLC | 11/14/2024 | 1.85 M | $36.15 M | 0.00% | 2.13% |
COMMODORE CAPITAL LP | 11/14/2024 | 1.80 M | $35.17 M | 12.97% | 2.07% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.78 M | $34.80 M | 2.39% | 2.05% |
FRANKLIN RESOURCES INC | 11/12/2024 | 1.59 M | $28.69 M | 1.48% | 1.83% |
TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 1.42 M | $27.82 M | 0.00% | 1.64% |
SIREN, L.L.C. | 11/13/2024 | 1.34 M | $26.18 B | 100.00% | 1.54% |
MORGAN STANLEY | 11/14/2024 | 1.21 M | $23.58 M | -9.17% | 1.39% |
CITADEL ADVISORS LLC | 11/14/2024 | 1.19 M | $23.23 M | 17.36% | 1.37% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.05 M | $20.59 M | 17.79% | 1.21% |
ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 1.05 M | $20.56 M | -39.24% | 1.21% |
BOXER CAPITAL, LLC | 11/14/2024 | 1.00 M | $19.54 M | 0.00% | 1.15% |
CANDRIAM S.C.A. | 11/13/2024 | 906,482 | $17.71 M | 0.00% | 1.04% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 845,194 | $16.52 M | 148.97% | 0.97% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 709,484 | $13.86 M | -14.71% | 0.82% |
PROSIGHT MANAGEMENT, LP | 11/14/2024 | 705,109 | $13.78 M | 11.94% | 0.81% |
AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 687,785 | $13.44 M | 5.81% | 0.79% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 624,952 | $12.21 M | 2.31% | 0.72% |
SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 610,087 | $11.92 M | -0.12% | 0.70% |
WALLEYE CAPITAL LLC | 11/14/2024 | 571,365 | $11.16 M | 661.00% | 0.66% |
ALETHEA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 553,542 | $10.82 M | 108.17% | 0.64% |
D. E. SHAW & CO., INC. | 11/14/2024 | 423,208 | $8.27 M | 12.64% | 0.49% |
JPMORGAN CHASE & CO | 11/08/2024 | 409,241 | $8.00 M | 0.76% | 0.47% |
DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 408,368 | $7.98 M | -3.57% | 0.47% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 350,415 | $6.85 M | -12.95% | 0.40% |
SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 296,884 | $5.80 B | -64.02% | 0.34% |
ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 294,081 | $5.75 M | -4.13% | 0.34% |
ALGERT GLOBAL LLC | 11/12/2024 | 272,276 | $5.32 M | 4.41% | 0.31% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 256,880 | $5.02 M | -1.97% | 0.30% |
RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 252,770 | $4.94 M | 15.71% | 0.29% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 208,239 | $4.07 M | -23.52% | 0.24% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 205,678 | $4.02 M | -19.62% | 0.24% |
ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 197,000 | $3.85 M | 20.86% | 0.23% |
EVERSEPT PARTNERS, LP | 11/14/2024 | 192,398 | $3.76 M | 166.05% | 0.22% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 189,103 | $3.70 M | 100.00% | 0.22% |
RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 166,526 | $3.25 M | 0.00% | 0.19% |
BARCLAYS PLC | 11/19/2024 | 165,484 | $3.23 M | 104.50% | 0.19% |
WOODLINE PARTNERS LP | 11/14/2024 | 143,207 | $2.80 M | 0.00% | 0.16% |
PROPEL BIO MANAGEMENT, LLC | 11/13/2024 | 130,000 | $2.54 M | 0.00% | 0.15% |
UBS GROUP AG | 11/14/2024 | 129,816 | $2.54 M | 41.45% | 0.15% |
Kura Oncology, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of KURA shares?
During the previous two years, 214 institutional investors and hedge funds held shares of Kura Oncology, Inc.. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 7.65 M
BlackRock Funding, Inc. /DE: 7.16 M
EcoR1 Capital, LLC: 5.81 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 5.41 M
Paradigm Biocapital Advisors LP: 4.33 M
Avoro Capital Advisors LLC: 3.54 M
-
What percentage of Kura Oncology, Inc. stock is owned by institutional investors?
94.66% of Kura Oncology, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at KURA ?
Institutional investors have bought a total of 85.88 M shares in the last 24 months. This purchase volume represents approximately $932.64 M in transactions.